Scientific Advisory Committee

OCRA’s Scientific Advisory Committee (SAC) comprises renowned doctors and researchers in the field of gynecologic oncology who help determine which grants we fund. This panel of esteemed experts reviews hundreds of proposals annually, selecting the most innovative and promising.

Meet the SAC

Ronald D. Alvarez, MD, MBA, Chair

Vanderbilt University Medical Center

Deborah K. Armstrong, MD

Johns Hopkins School of Medicine

Robert C. Bast Jr., MD

MD Anderson Cancer Center

Andrew Berchuck, MD

Duke Comprehensive Cancer Center

Jonathan S. Berek, MD, MMS

Stanford University School of Medicine

Benjamin Bitler, PhD

University of Colorado

Molly Brewer, DVM, MD, MS

University of Connecticut Health Center

Ronald Buckanovich, MD, PhD

Magee-Womens Research Institute

Jeremy Chien, PhD

California Davis School of Medicine

Kathleen Cho, MD

University of Michigan Medical School

Robert L. Coleman, MD

Vaniam Group

Jose Conejo-Garcia, MD, PhD

Duke University

Oliver Dorigo, MD, PhD

Stanford University

Katherine Fuh, MD, PhD

University of California, San Francisco

Gillian Hanley, PhD

University of British Columbia

Gwen Harding-Peets, PhD

Patient Advocate

David Huntsman, MD, FRCPC, FCCMG

University of British Columbia

Beth Y. Karlan, MD

UCLA Medical Center

Dineo Khabele, MD

Washington University School of Medicine in St. Louis

Joyce Liu, MD

Dana Farber Cancer Institute and Harvard Medical School

Daniela Matei, MD

Northwestern University Feinberg School of Medicine

Ursula Matulonis, MD, Grants Oversight Chair

Dana-Farber Cancer Institute

Kathleen Moore, MD, MS

University of Oklahoma Health Sciences Center

Kenneth Nephew, PhD

University of Indiana

Sandra Orsulic, PhD

David Geffen School of Medicine at the University of California, Los Angeles (UCLA)

Celeste Leigh Pearce, PhD, MPH

University of Michigan

Carolyn D. Runowicz, MD

Florida International University

Sohrab Shah, PhD

Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College

Ie-Ming Shih, MD, PhD

Johns Hopkins University School of Medicine

Anil K. Sood, MD

MD Anderson Cancer Center

Kathryn Terry, ScD

Harvard T.H. Chan School of Public Health

Shelley Tworoger, PhD

Oregon Health and Science Center

Jason D. Wright, MD

Columbia University Medical Center

Former Members

Jeff Boyd, PhD
Carmel J. Cohen, MD
Alan D. D’Andrea, MD
Ronny I. Drapkin, MD, PhD
Annie Ellis
Ellen L. Goode, PhD
Susan Leighton
Ernst Lengyel, MD, PhD
Douglas A. Levine, MD
Carolyn Muller, MD, FACOG
Kunle Odunsi, MD, PhD
Bob Ozols, MD, PhD
Daniel J. Powell Jr., PhD
Stephen C. Rubin, MD
Michael Seiden, MD, PhD
Elizabeth Swisher, MD

Related Topics

The Overview: November 2025

Friends, As we approach the end of the year, one thing stands out above all else: this is a moment of unprecedented opportunity to accelerate progress against ovarian and all gynecologic cancers. And thanks to you, OCRA is rising to meet that moment — driving innovation, expanding support, and providing the community that so many … Continued

OCRA Board Member Laura Shawver, PhD, Named to Fierce 50 of 2025

Ovarian Cancer Research Alliance (OCRA) congratulates board member Laura Shawver, PhD, on her selection to the Fierce 50 of 2025, a leading industry award from Fierce Life Sciences recognizing individuals and organizations advancing what’s possible in health, science and patient care. Dr. Shawver was selected for her long-standing leadership in oncology research and drug development, … Continued

Make 2X the Difference with OCRA this Giving Season

YOU Can Help Shape the Future of Ovarian and Gynecologic Cancer Care We need your help to reach our important $2 million year-end fundraising goal. Your donation will be matched up to $500,000 through 12/31, thanks to a generous OCRA board member. That means your $1 = $2 to improve care, foster hope, and bring … Continued

Scientific Advisory Committee